Literature DB >> 23307452

Diagnostic pathway to amyotrophic lateral sclerosis (ALS): the significance of Babinski's sign in a unique patient and the necessity for a multidisciplinary approach.

Vincent Bulthuis1, Marielle Vlooswijk, Henk van Santbrink, Olaf Schijns.   

Abstract

In this case report, we present a patient with rare diagnosis of amyotrophic lateral sclerosis (ALS). In this patient, four different neurological disorders were diagnosed in a short-time period of 8 months. The first three diagnoses, chronic low back and leg pain, a left frontal gemistocytic astrocytoma WHO grade 2 and suspected Lyme's disease, could not fully explain the signs of physical examination. Finally, the diagnosis of ALS could reduce these signs to the same denominator.

Entities:  

Mesh:

Year:  2013        PMID: 23307452      PMCID: PMC3603900          DOI: 10.1136/bcr-2012-007018

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  Matthew C Kiernan; Steve Vucic; Benjamin C Cheah; Martin R Turner; Andrew Eisen; Orla Hardiman; James R Burrell; Margaret C Zoing
Journal:  Lancet       Date:  2011-02-04       Impact factor: 79.321

Review 2.  Amyotrophic lateral sclerosis.

Authors:  J D Mitchell; G D Borasio
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

3.  Trends and determinants of end-of-life practices in ALS in the Netherlands.

Authors:  M Maessen; Jan H Veldink; B D Onwuteaka-Philipsen; J M de Vries; J H J Wokke; G van der Wal; L H van den Berg
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

Review 4.  Inflammation and central nervous system Lyme disease.

Authors:  Brian A Fallon; Elizabeth S Levin; Pernilla J Schweitzer; David Hardesty
Journal:  Neurobiol Dis       Date:  2009-11-26       Impact factor: 5.996

5.  Mapping of the hypokalaemic periodic paralysis (HypoPP) locus to chromosome 1q31-32 in three European families.

Authors:  B Fontaine; J Vale-Santos; K Jurkat-Rott; J Reboul; E Plassart; C S Rime; A Elbaz; R Heine; J Guimarães; J Weissenbach
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.